Cholesterol and blood pressure values at baseline and after 15 days of dark-chocolate and white-chocolate consumption Characteristic Dark chocolate before.

Slides:

Advertisements

Similar presentations

1 Hypertension 2002: An Overview. 2 Leading Risks For Death (World Health Organization 1995)

Advertisements

Newly diagnosed hypertensive patients with type 2 diabetes (n = 1544) Randomisation Avoid ACE inhibitors/ beta-blockers (n = 390) Tight BP control (n =

Flow diagram showing study population of Chinese patients with type 2 diabetes mellitus and reasons for exclusion Yang X et al. CMAJ 2008;179:

NHANES III Prevalence of Hypertension* According to BMI

BHS Guidelines for the management of hypertension BHS IV, 2004 and Update of the NICE Hypertension Guideline, 2006 Guidelines for management of hypertension:

Who should have statins 18 th March Nonfatal MI CHD death Any major coronary event CABG PTCA Unspecified Any coronary revascularisation.

לדיובן הגנה כלייתית מוכחת בחולי סכרת מסוג 2, (היפרטנסיבים ונורמוטנסיבים) עם מיקרואלבומינוריה לדיובן הגנה כלייתית מוכחת בחולי סכרת מסוג 2, (היפרטנסיבים.

Age Adjusted Prevalence of Hypertension* Among Adults by Education in NYC, 2004 Data from: New York City Department of Health and Mental Hygiene, EpiQuery.

Liraglutide Promotes Natriuresis but Does Not Increase Circulating Levels of Atrial Natriuretic Peptide in Hypertensive Subjects With Type 2 Diabetes Featured.

Empagliflozin Reduces Blood Pressure in Patients With Type 2 Diabetes and Hypertension Featured Article: Ilkka Tikkanen, Kirsi Narko, Cordula Zeller, Alexandra.

Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Renal Denervation in Moderate Treatment-Resistant.

Study design: a randomized placebo- controlled crossover trial of 2 periods of 4 weeks Nicole A.J. van der Linde, et al. Hypertension 2006;47;

Dr John Cox Diabetes in Primary Care Conference Cork

Chocolate is Good for You!

Figure 1. Schedule of the study

Copyright © 2010 American Medical Association. All rights reserved.

Plots of clinic blood pressure (CBP) versus daytime ambulatory (ABP) and home bl.. Figure 1. Plots of clinic blood pressure (CBP) versus daytime ambulatory.

Ambulatory Blood Pressure Monitoring in Clinical Practice: A Review

Eoin O’Brien, DSc, MD, Eamon Dolan, MD, FRCPI Clinical Therapeutics

Trial profile for the pharmacokinetics and pharmacodynamics study in patients with dyslipidaemia (A) and the ambulatory blood pressure study (B) *Participants.

Flowchart of participants

by Michael D. Elliott, Ajoy Kapoor, Michele A. Parker, Dixon B

Mean 24-Hour, Daytime, and Night Ambulatory Systolic BP, Diastolic BP, and PP Before (Week 0) and After (Week 12) NAG and Placebo Intake in 37 Hypertensive.

Comparison of baseline characteristics in participants who subsequently had an incident cardiovascular event or new-onset diabetes in the Prospective.

by Katie Ayers, Loretta M. Byrne, Anthony DeMatteo, and Nancy J. Brown

Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension by.

Types of chocolates. Milk Chocolate Sweet Chocolate Dark Chocolate White Chocolate Liquor Chocolate.

Relative mortality risk associated with quartiles of systolic blood pressure compared with systolic

Oana Dickinson et al. JACEP 2016;2:

Mean BP from initial visit to four years

Krzysztof Narkiewicz et al. BTS 2016;1:

Summary of DURATION development program select efficacy results: absolute difference in change in A1C, body weight, systolic blood pressure, and LDL cholesterol.

Hazard ratios (HR) for ESRD or death for 1-SD increase in systolic BP: Home recording vs clinic measurement BP measurement HR for each 1-SD increase.

Time point Difference in systolic BP (mm Hg) p

Description of studies for pooled analyses

End point Net change with soy supplements vs control (95% CI) p

Chapter 28 Nutrition, Lifestyle, and Hypertension

Plot of average differences in arterial blood pressure using the two methods in mm Hg against both methods for systolic blood pressure (A) and diastolic.

Level of risk factor control in the overall sample and by gender

Adjusted relative risk for developing end-stage renal disease (ESRD) associated with blood-pressure level BP level (mm Hg) Adjusted relative risk 95%

Ratio of relative risks of heart disease and stroke associated with higher blood pressure, smoking, type I and II diabetes, and higher cholesterol in women.

Clinical Characteristics and Atheroma Burden of Subjects at Baseline Stratified According to Gender Nicholls SJ. et al. J Am Coll Cardiol 2007;49:

Krzysztof Narkiewicz et al. BTS 2016;1:

Volume 383, Issue 9932, Pages (May 2014)

Variable WKY C WKY H WKY R WKY H+R SHR C SHR H SHR R SHR H+R

Baseline Characteristics, Blood Pressures, and Laboratory Values

Baseline Characteristics of the Subjects*

DENERHTN Trial design: Patients with resistant hypertension were randomized to renal denervation plus standardized stepped-care antihypertensive treatment.

Disposition of Patients in the Atherogenic Dyslipidemia Study

Baseline Lipid Parameters and Characteristics Among 3110 Men According to Quintiles of Total Cholesterol Ruben O. Halperin et al, Hypertension 2006;47;45-50.

Flow chart of the 1683 study members at age 60–64 years by hypertension (HT) status. Flow chart of the 1683 study members at age 60–64 years by hypertension.

Demographic and Clinical Characteristics (means ± SD or %) of Subjects in Different Office SBP and DBP Categories Mancia G et al Hypertension. 2005;45:1072.

RECORD Study: Enrollment and Outcomes

Change in (A) systolic blood pressure and (B) diastolic blood pressure over 5 years in response to 12-week intensive lifestyle intervention in a real-world.

PROSPER: trial design

Forest plot of CIMT progression rate for atorvastatin treatment versus placebo for 3 years by baseline serum 25-hydroxyvitamin D status. Forest plot of.

Percentage of patients with type 2 diabetes with A1C < 7% (n = 248), blood pressure > 130/80 mmHg (n = 248), and LDL cholesterol < 100 mg/dl (n = 207)

Flow of study participants

End point Valsartan Valsartan+HCTZ p

Mean adjusted levels in each group for the following cardiometabolic risk factors at 3 and 12 months postpartum: (A) systolic blood pressure, (B) diastolic.

Prevalence of cardiovascular risk factors compared with the Canadian population. Prevalence of cardiovascular risk factors compared with the Canadian population.

J. David Spence, BA, MBA, MD Canadian Journal of Cardiology

Mean Pulmonary Artery Pressure Change Post-Thrombectomy Average pre-procedural mean pulmonary artery pressure (mPAP) in patients with pulmonary hypertension.

Effects of placebo or carvedilol CR on 24-hour mean systolic blood pressure and diastolic blood pressure obtained by ambulatory monitoring in hypertensive.

The combined effects of low sodium and the DASH diet according to baseline blood pressure. The combined effects of low sodium and the DASH diet according.

Pulmonary artery pressure in a) healthy subjects and b) pulmonary hypertension (PH) subjects. Pulmonary artery pressure in a) healthy subjects and b) pulmonary.

Percentage change from baseline in homeostatic model assessment (HOMA) score, vascular endothelial growth factor (VEGF), epidermal growth factor (EGF),

The hypertension care cascade, South Africa 2011–2012.

Relationship between 6-month all-cause mortality and the three types of heart failure adjusted for age ≥75 years, peripheral edema at admission, systolic.

Average change in blood pressure (BP) from recruitment to 6-month postrecruitment in intervention and control patients >50 years included due to having.

Presentation transcript:

Cholesterol and blood pressure values at baseline and after 15 days of dark-chocolate and white-chocolate consumption Characteristic Dark chocolate before (n=10) Dark chocolate after (n=10) White chocolate before (n=10) White chocolate after (n=10) Total cholesterol (mmol/L) 5.4 5.0* LDL cholesterol (mmol/L) 3.4 3.0† 24-hour systolic blood pressure (ambulatory blood pressure monitoring) (mm Hg) 135.5 123.6‡ 135.6 134.7 24-hour diastolic blood-pressure (ambulatory blood-pressure monitoring)(mm Hg) 88.0 79.6‡ 87.6 87.5 *p=0.0003 dark-chocolate vs baseline and white-chocolate values †p<0.05 dark-chocolate vs baseline and white-chocolate values ‡p<0.0001 dark-chocolate vs baseline and white-chocolate value Grassi D et al. Hypertension 2005; available at http://hyper.ahajournals.org